Identification of cancer stem cell characteristics in liver hepatocellular carcinoma by WGCNA analysis of transcriptome stemness index

Identification of cancer stem cell characteristics in liver hepatocellular carcinoma by WGCNA analysis of transcriptome stemness index

Abstract Cancer stem cells (CSCs) are characterized by self‐renewal and ‐differential potential as compared to common cancer cells and play an important role in the development and therapeutic resistance of liver hepatocellular carcinoma (LIHC). However, the specific pathogenesis of LIHC stem cells...

Full description

Bibliographic Details
Main Authors:	Kun‐Hao Bai, Si‐Yuan He, Ling‐Ling Shu, Wei‐Da Wang, Shi‐Yong Lin, Qian‐Yi Zhang, Liang Li, Lei Cheng, Yu‐Jun Dai
Format:	Article
Language:	English
Published:	Wiley 2020-06-01
Series:	Cancer Medicine
Subjects:	biomarker cancer stem cells (CSCs) co‐expression network liver hepatocellular carcinoma (LIHC) mRNAsi index WGCNA analysis
Online Access:	https://doi.org/10.1002/cam4.3047

Similar Items

Integrated Bioinformatics Analysis Identifies a New Stemness Index-Related Survival Model for Prognostic Prediction in Lung Adenocarcinoma
by: Shaohui Hou, et al.
Published: (2022-04-01)

Identification of key genes controlling breast cancer stem cell characteristics via stemness indices analysis
by: Jianying Pei, et al.
Published: (2020-02-01)

Identification of Biomarkers for Controlling Cancer Stem Cell Characteristics in Bladder Cancer by Network Analysis of Transcriptome Data Stemness Indices
by: Shen Pan, et al.
Published: (2019-07-01)

Identification of cancer stemness and M2 macrophage-associated biomarkers in lung adenocarcinoma
by: XiaoFang Wang, et al.
Published: (2023-09-01)

Integrative Analysis of Gene Expression Through One-Class Logistic Regression Machine Learning Identifies Stemness Features in Multiple Myeloma
by: Chunmei Ban, et al.
Published: (2021-08-01)

Implications of Stemness Features in 1059 Hepatocellular Carcinoma Patients from Five Cohorts: Prognosis, Treatment Response, and Identification of Potential Compounds
by: Haoming Mai, et al.
Published: (2022-01-01)

Integrative stemness characteristics associated with prognosis and the immune microenvironment in lung adenocarcinoma
by: Han Wang, et al.
Published: (2022-12-01)

Identification of cancer stem cell-related biomarkers in intestinal-type and diffuse-type gastric cancer by stemness index and weighted correlation network analysis
by: Rui Guo, et al.
Published: (2020-11-01)

scRNA-seq revealed high stemness epithelial malignant cell clusters and prognostic models of lung adenocarcinoma
by: GuoYong Lin, et al.
Published: (2024-02-01)

mRNAsi-related genes can effectively distinguish hepatocellular carcinoma into new molecular subtypes
by: Canbiao Wang, et al.
Published: (2022-01-01)

A novel stemness classification in acute myeloid leukemia by the stemness index and the identification of cancer stem cell-related biomarkers
by: Yue Huang, et al.
Published: (2023-06-01)

Development and validation of a hypoxia-stemness-based prognostic signature in pancreatic adenocarcinoma
by: Xiong Tian, et al.
Published: (2022-07-01)

Integrated analysis revealing a novel stemness-metabolism-related gene signature for predicting prognosis and immunotherapy response in hepatocellular carcinoma
by: Yuxin Wang, et al.
Published: (2023-08-01)

Potential Role of S-Palmitoylation in Cancer Stem Cells of Lung Adenocarcinoma
by: Yitong Zhang, et al.
Published: (2021-09-01)

Exploring the role of tumor stemness and the potential of stemness-related risk model in the prognosis of intrahepatic cholangiocarcinoma
by: Yuan Yue, et al.
Published: (2023-01-01)

Identification and Validation of the Prognostic Stemness Biomarkers in Bladder Cancer Bone Metastasis
by: Yao Kang, et al.
Published: (2021-03-01)

mRNAsi-related metabolic risk score model identifies poor prognosis, immunoevasive contexture, and low chemotherapy response in colorectal cancer patients through machine learning
by: Meilin Weng, et al.
Published: (2022-08-01)

Identification of Prognosis Biomarkers for High-Grade Serous Ovarian Cancer Based on Stemness
by: Zhihang Wang, et al.
Published: (2022-03-01)

Construction of Bone Metastasis-Specific Regulation Network Based on Prognostic Stemness-Related Signatures in Breast Invasive Carcinoma
by: Runzhi Huang, et al.
Published: (2021-01-01)

Shared Genes and Molecular Mechanisms between Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma Established by WGCNA Analysis
by: He He, et al.
Published: (2023-09-01)

Identification of the Potential Prognosis Biomarkers in Hepatocellular Carcinoma: An Analysis Based on WGCNA and PPI
by: Huang J, et al.
Published: (2021-12-01)

Identification and in vitro and in vivo validation of the key role of GSDME in pyroptosis-related genes signature in hepatocellular carcinoma
by: Xinyi Chen, et al.
Published: (2023-05-01)

An N6-methyladenosine regulation- and mRNAsi-related prognostic index reveals the distinct immune microenvironment and immunotherapy responses in lower-grade glioma
by: Guihua Tang, et al.
Published: (2023-06-01)

Identification of key genes in hepatocellular carcinoma associated with exposure to TCDD and α-endosulfan by WGCNA
by: Yanyuan Lu, et al.
Published: (2023-03-01)

Prognostic prediction using a gene signature developed based on exhausted T cells for liver cancer patients
by: Yu Zhou, et al.
Published: (2024-03-01)

Identification of Diagnostic Biomarkers and Subtypes of Liver Hepatocellular Carcinoma by Multi-Omics Data Analysis
by: Xiao Ouyang, et al.
Published: (2020-09-01)

Therapeutic effect and transcriptome-methylome characteristics of METTL3 inhibition in liver hepatocellular carcinoma
by: Qingbin Liu, et al.
Published: (2023-11-01)

Clinical Diagnostic and Prognostic Potential of NDRG1 and NDRG2 in Hepatocellular Carcinoma Patients
by: Shaohua Xu, et al.
Published: (2022-06-01)

Prognostic value and immunological role of BAIAP2L2 in liver hepatocellular carcinoma: A pan-cancer analysis
by: Xiudan Han, et al.
Published: (2022-10-01)

Activated Carbon nanoparticles Loaded with Metformin for Effective Against Hepatocellular Cancer Stem Cells
by: Sun L, et al.
Published: (2023-05-01)

ACYP1 Is a Pancancer Prognostic Indicator and Affects the Immune Microenvironment in LIHC
by: Lingyi Zhou, et al.
Published: (2022-05-01)

Identification and validation of functional roles for three MYC-associated genes in hepatocellular carcinoma
by: Sha Li, et al.
Published: (2023-12-01)

The role of liver cancer stem cells in hepatocellular carcinoma metastasis
by: Qinghui Niu, et al.
Published: (2024-12-01)

Identification of ZBTB9 as a potential therapeutic target against dysregulation of tumor cells proliferation and a novel biomarker in Liver Hepatocellular Carcinoma
by: Zhenshan Zhang, et al.
Published: (2022-12-01)

Machine learning-based construction of a ferroptosis and necroptosis associated lncRNA signature for predicting prognosis and immunotherapy response in hepatocellular cancer
by: Lei Zhao, et al.
Published: (2023-04-01)

Identification of hepatocellular carcinoma-related subtypes and development of a prognostic model: a study based on ferritinophagy-related genes
by: Ganggang Wang, et al.
Published: (2023-08-01)

The combined characteristics of cholesterol metabolism and the immune microenvironment may serve as valuable biomarkers for both the prognosis and treatment of hepatocellular carcinoma
by: Weiyu Bai
Published: (2023-12-01)

Construction and validation of a prognostic marker and risk model for HCC ultrasound therapy combined with WGCNA identification
by: Yunlong Bi, et al.
Published: (2022-10-01)

Prognostic Value of Long Noncoding RNA DLEU2 and Its Relationship with Immune Infiltration in Kidney Renal Clear Cell Carcinoma and Liver Hepatocellular Carcinoma
by: Fu S, et al.
Published: (2021-11-01)

Pan-cancer analysis of SYNGR2 with a focus on clinical implications and immune landscape in liver hepatocellular carcinoma
by: Chunxun Liu, et al.
Published: (2023-05-01)